COL P00533-1 GLY 000329 (Collection)

Id Namespace:

GlyGen Project

Identifier Namespace (Entity type)

Dcc Asset:

glygen cfde 2025 sept data submission.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Description:Information for protein P00533-1 in the context of file GLY_000329

Creation Time:2025-09-03T19:07:43-04:00

Results found

Linked to

	Label	Description
	Portal Project (Entity type)	GlyGen portal
	human proteoform glycosylation sites glyconnect.csv File (Entity type)	A 11.6 MB file from GlyGen as part of the Portal project
	alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->6)]-alpha-D-mannosyl-(1->6)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine Compound (Entity type)	A Compound
	Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4(Fucalpha1-6)GlcNAcbeta Compound (Entity type)	A Compound
	alpha-D-Manp-(1->2)-alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Compound (Entity type)	A Compound
	Neu5Aca2-3Galb1-4GlcNAcb1-2Mana1-6(Neu5Aca2-3Galb1-4GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4(Fuca1-6)GlcNAcb Compound (Entity type)	A Compound
	Fucalpha1-6[Galbeta1-4GlcNAcbeta1-2(Galbeta1-4GlcNAcbeta1-6)Manalpha1-6(Galbeta1-4GlcNAcbeta1-2Manalpha1-3)Manbeta1-4GlcNAcbeta1-4]GlcNAcbeta Compound (Entity type)	A Compound
	Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta Compound (Entity type)	A Compound
	Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-2)Manalpha1-6(Galbeta1-4GlcNAcbeta1-2Manalpha1-3)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta Compound (Entity type)	A Compound
	Manalpha1-2Manalpha1-6(Manalpha1-3)Manalpha1-6(Manalpha2Manalpha2Manalpha1-3)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta Compound (Entity type)	A Compound

Portal

Project (Entity type)

GlyGen portal

human proteoform glycosylation sites glyconnect.csv

File (Entity type)

A 11.6 MB file from GlyGen as part of the Portal project

alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->3)-[alpha-D-mannosyl-(1->6)]-alpha-D-mannosyl-(1->6)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Compound (Entity type)

A Compound

Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4(Fucalpha1-6)GlcNAcbeta

Compound (Entity type)

A Compound

alpha-D-Manp-(1->2)-alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc

Compound (Entity type)

A Compound

Neu5Aca2-3Galb1-4GlcNAcb1-2Mana1-6(Neu5Aca2-3Galb1-4GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4(Fuca1-6)GlcNAcb

Compound (Entity type)

A Compound

Fucalpha1-6[Galbeta1-4GlcNAcbeta1-2(Galbeta1-4GlcNAcbeta1-6)Manalpha1-6(Galbeta1-4GlcNAcbeta1-2Manalpha1-3)Manbeta1-4GlcNAcbeta1-4]GlcNAcbeta

Compound (Entity type)

A Compound

Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-2Manalpha1-3(Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-2Manalpha1-6)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta

Compound (Entity type)

A Compound

Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-2)Manalpha1-6(Galbeta1-4GlcNAcbeta1-2Manalpha1-3)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta

Compound (Entity type)

A Compound

Manalpha1-2Manalpha1-6(Manalpha1-3)Manalpha1-6(Manalpha2Manalpha2Manalpha1-3)Manbeta1-4GlcNAcbeta1-4GlcNAcbeta

Compound (Entity type)

A Compound

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.